Dietary oleuropein inhibits tumor angiogenesis and lymphangiogenesis in the B16F10 melanoma allograft model: A mechanism for the suppression of high-fat diet-induced solid tumor growth and lymph node metastasis

Oncotarget

Volumn 8, Issue 19, 2017, Pages 32027-32042

  Song, Hyerim ^a   Lim, Do Young ^b   Jung, Jae In ^c   Cho, Han Jin ^a,d   Park, So Young ^a,e   Kwon, Gyoo Taik ^a,e,f   Kang, Young Hee ^a   Lee, Ki Won ^d,e,g   Choi, Myung Sook ^h   Park, Jung Han Yoon ^a,e,g  

^a Hallym University   (South Korea)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Seoul National University   (South Korea)

^e Seoul National University   (South Korea)

^f BerryandBio Food Research Institute   (South Korea)

^g Seoul National University   (South Korea)

^h Kyungpook National University   (South Korea)

Author keywords

Angiogenesis; Lymphangiogenesis; Melanoma; Metastasis; Oleuropein

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICROSOMAL AMINOPEPTIDASE; OLEUROPEIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; ANGIOGENESIS INHIBITOR; IRIDOID; VASCULOTROPIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B16-F10 CELL LINE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL VACUOLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; ENDOTHELIUM CELL; HYPOXIA; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC ENDOTHELIAL CELL; MACROPHAGE; MALE; MELANOMA; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; ADIPOSE TISSUE; ALLOGRAFT; ANIMAL; CELL PROLIFERATION; DIETARY SUPPLEMENT; DRUG EFFECT; EXPERIMENTAL MELANOMA; LIPID DIET; LIPID METABOLISM; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR VOLUME;

ADIPOSE TISSUE; ALLOGRAFTS; ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL PROLIFERATION; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; HYPOXIA; IRIDOID GLUCOSIDES; IRIDOIDS; LIPID METABOLISM; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; NEOVASCULARIZATION, PATHOLOGIC; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 85019095328     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.16757     Document Type: Article

References (62)

1. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. Journal of obesity. 2013; 2013:291546
2. Garcia-Jimenez C, Gutierrez-Salmeron M, Chocarro-Calvo A, Garcia-Martinez JM, Castano A, De la Vieja A. From obesity to diabetes and cancer: epidemiological links and role of therapies. British journal of cancer. 2016; 114:716-722
3. Sergentanis TN, Antoniadis AG, Gogas HJ, Antonopoulos CN, Adami HO, Ekbom A, Petridou ET. Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. European journal of cancer. 2013; 49:642-657
4. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England Journal of Medicine. 2003; 348:1625-1638
5. Jung JI, Cho HJ, Jung YJ, Kwon SH, Her S, Choi SS, Shin SH, Lee KW, Park JH. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: roles of adipocytes and M2-macrophages. International Journal of Cnacer. 2015; 136:258-270
6. Bravo-Cordero JJ, Hodgson L, Condeelis J. Directed cell invasion and migration during metastasis. Current opinion in cell biology. 2012; 24:277-283
7. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. The American journal of pathology. 1998; 153:333-339
8. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nature reviews Cancer. 2002; 2:563-572
9. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nature reviews Cancer. 2002; 2:573-583
10. Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nature reviews Cancer. 2014; 14:159-172
11. Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vascular health and risk management. 2006; 2:213-219
12. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nature reviews Cancer. 2002; 2:795-803
13. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S, Jaattela M, Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer research. 2001; 61:1786-1790
14. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002; 296:1883-1886
15. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Current topics in microbiology and immunology. 1999; 237:1-30
16. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer metastasis reviews. 2006; 25:315-322
17. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nature Medicine. 2011; 17:1498-1503
18. Rahimi N, Saulnier R, Nakamura T, Park M, Elliott B. Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA and Cell Biology. 1994; 13:1189-1197
19. Brandon EL, Gu JW, Cantwell L, He Z, Wallace G, Hall JE. Obesity promotes melanoma tumor growth: role of leptin. Cancer Biology and Therapy. 2009; 8:1871-1879
20. Pandey V, Vijayakumar MV, Ajay AK, Malvi P, Bhat MK. Diet-induced obesity increases melanoma progression: involvement of Cav-1 and FASN. International Journal of Cancer. 2012; 130:497-508
21. Coelho P, Almeida J, Prudencio C, Fernandes R, Soares R. Effect of Adipocyte Secretome in Melanoma Progression and Vasculogenic Mimicry. Journal of Cellular Biochemistry. 2016; 117:1697-1706
22. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000; 407:249-257
23. Risau W. Mechanisms of angiogenesis. Nature. 1997; 386:671-674
24. Park H, Kim M, Kwon GT, Lim do Y, Yu R, Sung MK, Lee KW, Daily JW, 3rd and Park JH. A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice. Molecular carcinogenesis. 2012; 51: 869-880
25. Liao HY, Wang GP, Huang SH, Li Y, Cai SW, Zhang J, Chen HG, Wu WB. HIF-1alpha silencing suppresses growth of lung adenocarcinoma A549 cells through induction of apoptosis. Molecular medicine reports. 2014; 9:911-915
26. She Q, Xia S, Deng SB, Du JL, Li YQ, He L, Xiao J, Xiang YL. Angiogenesis in a rat model following myocardial infarction induced by hypoxic regulation of VEGF(1)(6)(5) gene-transfected EPCs. Molecular medicine reports. 2012; 6:1281-1287
27. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature. 1992; 359:843-845
28. Semenza GL. Transcriptional regulation by hypoxiainducible factor 1 molecular mechanisms of oxygen homeostasis. Trends in cardiovascular medicine. 1996; 6:151-157
29. Kostomoiri M, Fragkouli A, Sagnou M, Skaltsounis LA, Pelecanou M, Tsilibary EC, Tzinia AK. Oleuropein, an anti-oxidant polyphenol constituent of olive promotes alpha-secretase cleavage of the amyloid precursor protein (AbetaPP). Cellular and molecular neurobiology. 2013; 33:147-154
30. Bisignano G, Tomaino A, Lo Cascio R, CrisafiG, Uccella N, Saija A. On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. The Journal of pharmacy and pharmacology. 1999; 51:971-974
31. Lepore SM, Morittu VM, Celano M, Trimboli F, Oliverio M, Procopio A, Di Loreto C, Damante G, Britti D, Bulotta S, Russo D. Oral Administration of Oleuropein and Its Semisynthetic Peracetylated Derivative Prevents Hepatic Steatosis, Hyperinsulinemia, and Weight Gain in Mice Fed with High Fat Cafeteria Diet. International journal of endocrinology. 2015; 2015:431453
32. Hamdi HK, Castellon R. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochemical and biophysical research communications. 2005; 334:769-778
33. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA, Jr. Body-mass index and symptoms of gastroesophageal reflux in women. The New England journal of medicine. 2006; 354:2340-2348
34. Toro AL, Costantino NS, Shriver CD, Ellsworth DL, Ellsworth RE. Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients. BMC obesity. 2016; 3:22
35. Hanyuda A, Ogino S, Rong Qian Z, Nishihara R, Song M, Mima K, Inamura K, Masugi Y, Wu K, Meyerhardt JA, Chan AT, Fuchs CS, Giovannucci EL, et al. Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. International journal of cancer. 2016; 139:854-68
36. Kuem N, Song SJ, Yu R, Yun JW, Park T. Oleuropein attenuates visceral adiposity in high-fat diet-induced obese mice through the modulation of WNT10b-and galaninmediated signalings. Molecular nutrition & food research. 2014; 58:2166-2176
37. Drira R, Chen S, Sakamoto K. Oleuropein and hydroxytyrosol inhibit adipocyte differentiation in 3 T3-L1 cells. Life sciences. 2011; 89:708-716
38. de Bock M, Derraik JG, Brennan CM, Biggs JB, Morgan PE, Hodgkinson SC, Hofman PL, Cutfield WS. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebocontrolled, crossover trial. PloS one. 2013; 8:e57622
39. Scoditti E, Calabriso N, Massaro M, Pellegrino M, Storelli C, Martines G, De Caterina R, Carluccio MA. Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Archives of biochemistry and biophysics. 2012; 527:81-89
40. Semenza GL. Targeting HIF-1 for cancer therapy. Nature reviews Cancer. 2003; 3:721-732
41. Ji RC. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. Cancer letters. 2014; 346:6-16
42. Cardeno A, Sanchez-Hidalgo M, Rosillo MA, Alarcon de la Lastra C. Oleuropein, a secoiridoid derived from olive tree, inhibits the proliferation of human colorectal cancer cell through downregulation of HIF-1alpha. Nutr Cancer. 2013; 65:147-156
43. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, Gorlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arteriosclerosis, thrombosis, and vascular biology. 2007; 27:755-761
44. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, Gorlach A. Hypoxia up-regulates hypoxiainducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Molecular biology of the cell. 2007; 18:4691-4697
45. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental cell research. 2006; 312:549-560
46. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends in immunology. 2004; 25:387-395
47. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nature medicine. 1999; 5:1359-1364
48. Yoshiji H, Kuriyama S, Ways DK, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Tsujinoue H, Nakatani T, Shibuya M, Fukui H. Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer research. 1999; 59:4413-4418
49. Zhang Y, Nowicka A, Solley TN, Wei C, Parikh A, Court L, Burks JK, AndreeffM, Woodward WA, Dadbin A, Kolonin MG, Lu KH, Klopp AH. Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers. PloS one. 2015; 10:e0136361
50. Han J, Talorete TP, Yamada P, Isoda H. Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology. 2009; 59:45-53
51. Hassan ZK, Elamin MH, Daghestani MH, Omer SA, Al-Olayan EM, Elobeid MA, Virk P, Mohammed OB. Oleuropein induces anti-metastatic effects in breast cancer. Asian Pacific journal of cancer prevention. 2012; 13: 4555-4559
52. Yao J, Wu J, Yang X, Yang J, Zhang Y, Du L. Oleuropein induced apoptosis in HeLa cells via a mitochondrial apoptotic cascade associated with activation of the c-Jun NH2-terminal kinase. Journal of pharmacological sciences. 2014; 125:300-311
53. Secme M, Eroglu C, Dodurga Y, Bagci G. Investigation of anticancer mechanism of oleuropein via cell cycle and apoptotic pathways in SH-SY5Y neuroblastoma cells. Gene. 2016; 585:93-99
54. Del Boccio P, Di Deo A, De Curtis A, Celli N, Iacoviello L, Rotilio D. Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. Journal of chromatography B, Analytical technologies in the biomedical and life sciences. 2003; 785:47-56
55. Cho HJ, Jung JI, Lim DY, Kwon GT, Her S, Park JH, Park JH. Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model. Breast cancer research. 2012; 14:R81
56. Yeung OW, Lo CM, Ling CC, Qi X, Geng W, Li CX, Ng KT, Forbes SJ, Guan XY, Poon RT, Fan ST, Man K. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. Journal of hepatology. 2015; 62:607-616
57. Tsuboki J, Fujiwara Y, Horlad H, Shiraishi D, Nohara T, Tayama S, Motohara T, Saito Y, Ikeda T, Takaishi K, Tashiro H, Yonemoto Y, Katabuchi H, et al. Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages. Scientific reports. 2016; 6:29588
58. Prieur X, Mok CY, Velagapudi VR, Nunez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi JK, Dopazo J, Oresic M, et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. 2011; 60:797-809
59. Dzitoyeva S, Chen H, Manev H. 5-lipoxygenaseactivating protein as a modulator of olanzapine-induced lipid accumulation in adipocyte. Journal of lipids. 2013; 2013:864593
60. Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clinica chimica acta. 2007; 375:20-35
61. Kim EJ, Kang YH, Schaffer BS, Bach LA, MacDonald RG, Park JH. Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6. Journal of cellular physiology. 2002; 190:92-100
62. Kim EJ, Shin M, Park H, Hong JE, Shin HK, Kim J, Kwon DY, Park JH. Oral administration of 3,3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. The Journal of nutrition. 2009; 139:2373-2379